Work

Syn3 provides high levels of intravesical adenoviral-mediated gene transfer for gene therapy of genetically altered urothelium and superficial bladder cancer

Year: 2002

Type: article

Source: Cancer Gene Therapy

DOI: 10.1038/sj.cgt.7700488

Authors: Motoyuki Yamashita, Charles J Rosser, Jain-Hua Zhou, Xin-Qiao Zhang, Robert J Connor, Heidrun Engler, Daniel C Maneval, Takashi Karashima, Bogdan A Czerniak, Colin P N Dinney, William F Benedict

Institutions: The University of Texas MD Anderson Cancer Center, Merck & Co., Inc., Rahway, NJ, USA (United States)

Language: English

Topic: Virus-based gene therapy research

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Retina Research Foundation, National Institutes of Health, University of Texas MD Anderson Cancer Center, National Cancer Institute

Awards: G1619438925, Cancer Center Support Grant

OpenAlex ID: W1993099037

FWCI: 2.168

Cites: 11

Cited by: 74

Related to: 10